Diagnosis of cerebrospinal fluid in Creutzfeldt-Jakob disease;Liquordiagnostik der Creutzfeldt-Jakob-krankheit (CJK)

Wiener Medizinische Wochenschrift

Volumn 148, Issue 4, 1998, Pages 96-100

  Bernheimer, H ^a,c   Gatterbauer, Brigitte ^a   Radbauer, Claudia ^a,b   Budka, H ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Osterreichischen Referenzzentrum M

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DODECYL SULFATE SODIUM; PRION PROTEIN;

ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CREUTZFELDT JAKOB DISEASE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUMINESCENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS;

14-3-3 PROTEINS; BLOTTING, WESTERN; CREUTZFELDT-JAKOB SYNDROME; DIAGNOSIS, DIFFERENTIAL; HUMANS; PRIONS; PROTEINS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TYROSINE 3-MONOOXYGENASE;

EID: 0031895643     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Blisard KS, Davis LE, Harrington MG, Lovell JK, Kornfeld M, Berger ML: Pre-mortem diagnosis of Creutzfeldt-Jakob disease by detection of abnormal cerebrospinal fluid proteins. J Neurol Sci 1990;99:75-81.
2. Budka H, Aguzzi A, Brown P, Brucher JM, Bugiani O, Gullotta F, Hallia M, Hauw JJ, Ironside JW, Jellinger K, Kretzschmar HA, Lantos PL, Masullo C, Schlote W, Tateishi J, Weller RO: Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 1995;5:459-466.
3. Burbelo PD, Hall A: Hot numbers in signal transduction. Curr Biol 1995;5:95-96.
4. Caughey B, Chesebro B: Prion protein and the transmissible spongiform encephalopathies. Trends Cell Biol 1997;7:56-62.
5. Chescbro B: Human TSE disease - viral or protein only? Nature Med 1997;3:491-492.
6. Collinge J, Whittington MA, Sidle KCL, Smith CJ, Palmer MS, Clarke AR, Jefferys JGR: Prion protein is necessary for normal synaptic function. Nature 1994;370:295-297.
7. Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF: Molecular analysis of prion strain variation and the aetiology of "new variant" CJD. Nature 1996;383:685-690.
8. Harrington MG, Merril CR, Asher DM, Gajdusek DC: Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. N Engl J Med 1986;315:279-283.
9. Finkenstaedt M, Szudra A, Zerr I, Poser S, Hise JH, Stoebner JM, Weber T: MR imaging of Creutzfeldt-Jakob disease. Radiology 1996;199:793-798.
10. Hill AF, Zeidler M, Ironside J, Collinge J: Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997;349:99-100.
11. Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG: The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996;355:924-980.
12. Jimi T, Wakayama Y, Shibuya S, Nakata H, Tomaru T, Takahashi Y, Kosaka K, Asano T, Kato K: High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease. Clin Chim Acta 1992;211:37-46.
13. Lee KH, Harringlon MG: Premortem diagnosis of Creutzfeldt-Jakob disease by cerebrospinal fluid analysis. Lancet 1996;348:887.
14. Macário ME, Moura-Neto V, Vaisman M, Araujo HMM, Buescu A, Cordeiro JGH, Chagas C: Abnormal proteins in the cerebrospinal fluid of a patient with Creutzfeldt-Jakob disease following administration of human pituitary growth hormone. Brazilian J Med Biol Res 1992;25:1127-1130.
15. Masters CL, Harris JO, Gajdusek DC, Gibbs CJ, Bernoulli C, Asher DM: Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 1979;5:177-188.
16. Poser S, Zerr I, Schulz-Schaeffer WJ, Kretzschmar HA, Felgenhauer K: Die Creutzteldt-Jakob-Krankheit. Eine Sphinx der heutigen Neurobiologie. Dtsch Med Wschr 1997;122:1099-1105.
17. Prusiner SB: Molecular biology of prion diseases. Science 1991;252:1515-1522.
18. Rosenmann H, Meiner Z, Kahana E, Halimi M, Lenetsky E, Abramsky O, Gabizon R: Detection of 14-3-3 protein in the CSF of genetic Creutzfeldt-Jakob disease. Neurology 1997;49:693-695.
19. Vermuyten K, Lowenthal A, Karcher D: Detection of neuron specific enolase concentrations in cerebrospinal fluid from patients with neurological disorders by means of a sensitive enzyme immunoassay. Clin Chim Acta 1990;187:69-78.
20. Wakayama Y, Shibuya S, Kawasc J, Sagawa F, Hashizume Y: High neuron-specific enolase levels of cerebrospinal fluid in the early stage of Creutzfeldt-Jakob disease. Klin Wschr 1987;65:798-801.
21. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch L, Poser S, Pocchiari M, Hofman A, Smith PG: A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-925.
22. Will RG, Zeidler M, Brown P, Harrington M, Lee KH, Kenney KL: Cerebrospinal-fluid test for new-variant Creulzfeldt-Jakob disease. Lancet 1996;348:955.
23. Zerr I, Bodemer M, Räcker S, Grosche S, Poser S, Kretzschmar HA, Weber T: Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet 1995;345:1609-1610.
24. Zerr I, Bodemer M, Otto M, Poser S, Windl O, Kretzschmar HA, Gefeller O, Weber T: Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid. Lancet 1996;348:846-849.
25. Zerr I, Bodemer M, Weber T: The 14-3-3 protein and transmissible spongiform encephalopathy. Letter to the Editor. N Engl J Med 1997;336:874.